{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:35:37Z","timestamp":1784194537049,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T00:00:00Z","timestamp":1116806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T00:00:00Z","timestamp":1116806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2005,7,1]]},"DOI":"10.1038\/sj.bmt.1705016","type":"journal-article","created":{"date-parts":[[2005,5,23]],"date-time":"2005-05-23T09:11:48Z","timestamp":1116839508000},"page":"99-105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature"],"prefix":"10.1038","volume":"36","author":[{"given":"A C","family":"Lankester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L F A","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N G","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R G M","family":"Bredius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H B","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"van der Burg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J D","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T G","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Egeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,23]]},"reference":[{"key":"BF1705016_CR1","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","volume":"38","author":"TA Seemayer","year":"1995","unstructured":"Seemayer TA, Gross TG, Egeler RM et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res 1995; 38: 471\u2013478.","journal-title":"Pediatr Res"},{"key":"BF1705016_CR2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1046\/j.1365-2141.2002.03851.x","volume":"119","author":"HB Gaspar","year":"2002","unstructured":"Gaspar HB, Sharifi R, Gilmour KC, Thrasher AJ . X-linked lymphoproliferative disease: clinical, diagnostic and molecular perspective. Br J Hematol 2002; 119: 585\u2013595.","journal-title":"Br J Hematol"},{"key":"BF1705016_CR3","first-page":"935","volume":"1","author":"DT Purtilo","year":"1995","unstructured":"Purtilo DT, Cassel CK, Yang JP, Harper R . X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet 1995; 1: 935\u2013940.","journal-title":"Lancet"},{"key":"BF1705016_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0002-9343(82)90923-8","volume":"73","author":"DT Purtilo","year":"1982","unstructured":"Purtilo DT, Sakamoto K, Barnabei V et al. Epstein\u2013Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med 1982; 73: 49\u201356.","journal-title":"Am J Med"},{"key":"BF1705016_CR5","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/1097-0142(19870415)59:8<1419::AID-CNCR2820590807>3.0.CO;2-P","volume":"59","author":"DS Harrington","year":"1987","unstructured":"Harrington DS, Weisenburger DD, Purtilo DT . Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 1987; 59: 1419\u20131429.","journal-title":"Cancer"},{"key":"BF1705016_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.1320400309","volume":"40","author":"HL Grierson","year":"1991","unstructured":"Grierson HL, Skare J, Hawk J et al. Immunoglobulin class and subclass deficiencies prior to Epstein\u2013Barr virus infection in males with X-linked lymphoproliferative disease. Am J Med Genet 1991; 40: 294\u2013297.","journal-title":"Am J Med Genet"},{"key":"BF1705016_CR7","first-page":"3118","volume":"96","author":"J Sumegi","year":"2000","unstructured":"Sumegi J, Huang D, Lanyi A et al. Correlation of mutations of the SH2D1A gene and Epstein\u2013Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000; 96: 3118\u20133125.","journal-title":"Blood"},{"key":"BF1705016_CR8","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.129.6.2532","volume":"129","author":"S Harada","year":"1982","unstructured":"Harada S, Sakamoto K, Seeley JK et al. Immune deficiency in the X-linked lymphoproliferative syndrome. I. Epstein\u2013Barr virus-specific defects. J Immunol 1982; 129: 2532\u20132535.","journal-title":"J Immunol"},{"key":"BF1705016_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1365-2249.1991.tb05580.x","volume":"83","author":"N Yasuda","year":"1991","unstructured":"Yasuda N, Lai PK, Rogers J, Purtilo DT . Defective control of Epstein\u2013Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease. Clin Exp Immunol 1991; 83: 10\u201316.","journal-title":"Clin Exp Immunol"},{"key":"BF1705016_CR10","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1172\/JCI110932","volume":"71","author":"JL Sullivan","year":"1983","unstructured":"Sullivan JL, Byron KS, Brewster FE et al. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. J Clin Invest 1983; 71: 1765\u20131778.","journal-title":"J Clin Invest"},{"key":"BF1705016_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/0090-1229(90)90054-T","volume":"54","author":"M Okano","year":"1990","unstructured":"Okano M, Pirruccello SJ, Grierson HL et al. Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-alpha. Clin Immunol Immunopathol 1990; 54: 410\u2013418.","journal-title":"Clin Immunol Immunopathol"},{"key":"BF1705016_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/2424","volume":"20","author":"AJ Coffey","year":"1998","unstructured":"Coffey AJ, Brooksbank RA, Brandau O et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 1998; 20: 129\u2013135.","journal-title":"Nat Genet"},{"key":"BF1705016_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/26683","volume":"395","author":"J Sayos","year":"1998","unstructured":"Sayos J, Wu C, Morra M et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 1998; 395: 462\u2013469.","journal-title":"Nature"},{"key":"BF1705016_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1034\/j.1600-065X.2003.00023.x","volume":"192","author":"S Latour","year":"2003","unstructured":"Latour S, Veillette A . Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol Rev 2003; 192: 212\u2013224.","journal-title":"Immunol Rev"},{"key":"BF1705016_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/376260a0","volume":"376","author":"BG Cocks","year":"1995","unstructured":"Cocks BG, Chang CC, Carballido JM et al. A novel receptor involved in T-cell activation. Nature 1995; 376: 260\u2013263.","journal-title":"Nature"},{"key":"BF1705016_CR16","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.4049\/jimmunol.162.12.6981","volume":"162","author":"SG Tangye","year":"1999","unstructured":"Tangye SG, Lazetic S, Woollatt E et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999; 162: 6981\u20136985.","journal-title":"J Immunol"},{"key":"BF1705016_CR17","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1093\/hmg\/8.13.2407","volume":"8","author":"O Brandau","year":"1999","unstructured":"Brandau O, Schuster V, Weiss M et al. Epstein\u2013Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum Mol Genet 1999; 8: 2407\u20132413.","journal-title":"Hum Mol Genet"},{"key":"BF1705016_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s004390051137","volume":"105","author":"L Yin","year":"1999","unstructured":"Yin L, Ferrand V, Lavoue MF et al. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients. Hum Genet 1999; 105: 501\u2013505.","journal-title":"Hum Genet"},{"key":"BF1705016_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.192.3.337","volume":"192","author":"S Parolini","year":"2000","unstructured":"Parolini S, Bottino C, Falco M et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein\u2013Barr virus-infected cells. J Exp Med 2000; 192: 337\u2013346.","journal-title":"J Exp Med"},{"key":"BF1705016_CR20","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.4049\/jimmunol.167.5.2657","volume":"167","author":"H Nakamura","year":"2001","unstructured":"Nakamura H, Zarycki J, Sullivan JL, Jung JU . Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome. J Immunol 2001; 167: 2657\u20132665.","journal-title":"J Immunol"},{"key":"BF1705016_CR21","doi-asserted-by":"publisher","first-page":"3821","DOI":"10.1182\/blood-2003-09-3359","volume":"103","author":"R Sharifi","year":"2004","unstructured":"Sharifi R, Sinclair JC, Gilmour KC et al. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease. Blood 2004; 103: 3821\u20133827.","journal-title":"Blood"},{"key":"BF1705016_CR22","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri1202","volume":"3","author":"P Engel","year":"2003","unstructured":"Engel P, Eck MJ, Terhorst C . The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol 2003; 3: 813\u2013821.","journal-title":"Nat Rev Immunol"},{"key":"BF1705016_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1046\/j.1365-2249.2001.01599.x","volume":"126","author":"K Nistala","year":"2001","unstructured":"Nistala K, Gilmour KC, Cranston T et al. X-linked lymphoproliferative disease: three atypical cases. Clin Exp Immunol 2001; 126: 126\u2013130.","journal-title":"Clin Exp Immunol"},{"key":"BF1705016_CR24","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/j.1365-2249.2004.02581.x","volume":"137","author":"D Eastwood","year":"2004","unstructured":"Eastwood D, Gilmour KC, Nistala K et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol 2004; 137: 584\u2013588.","journal-title":"Clin Exp Immunol"},{"key":"BF1705016_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1365-2141.2000.01884.x","volume":"108","author":"B Strahm","year":"2000","unstructured":"Strahm B, Rittweiler K, Duffner U et al. Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein\u2013Barr virus infection. Br J Haematol 2000; 108: 377\u2013382.","journal-title":"Br J Haematol"},{"key":"BF1705016_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1182\/blood-2004-07-2965","volume":"105","author":"M Milone","year":"2005","unstructured":"Milone M, Tsai DE, Hodinka RL et al. Treatment of primary Epstein\u2013Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell directed therapy. Blood 2005; 105: 994\u2013996.","journal-title":"Blood"},{"key":"BF1705016_CR27","first-page":"222","volume":"42","author":"AH Filipovich","year":"1986","unstructured":"Filipovich AH, Blazar BR, Ramsay NKC et al. Allogeneic bone marrow transplantation for X-linked lymphoproliferative syndrome. Transplantation 1986; 42: 222\u2013224.","journal-title":"Transplantation"},{"key":"BF1705016_CR28","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0140-6736(93)91413-G","volume":"342","author":"LL Williams","year":"1993","unstructured":"Williams LL, Rooney CM, Conley ME et al. Correction of Duncan's syndrome by allogeneic bone marrow transplantation. Lancet 1993; 342: 587\u2013588.","journal-title":"Lancet"},{"key":"BF1705016_CR29","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1056\/NEJM199311253292205","volume":"329","author":"MR Vowels","year":"1993","unstructured":"Vowels MR, Lam-Po-Tang R, Berdoukas V et al. Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. N Engl J Med 1993; 329: 1623\u20131625.","journal-title":"N Engl J Med"},{"key":"BF1705016_CR30","first-page":"655","volume":"13","author":"E Pracher","year":"1994","unstructured":"Pracher E, Panzer-Grumayer ER, Zoubek A et al. Successful bone marrow transplantation in a boy with X-linked lymphoproliferative syndrome and acute severe infectious mononucleosis. Bone Marrow Transplant 1994; 13: 655\u2013658.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705016_CR31","first-page":"741","volume":"17","author":"TG Gross","year":"1996","unstructured":"Gross TG, Filipovich AH, Conley ME et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 1996; 17: 741\u2013744.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705016_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/sj.bmt.1701389","volume":"22","author":"T Hoffmann","year":"1998","unstructured":"Hoffmann T, Heilman C, Madsen HO et al. Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP). Bone Marrow Transplant 1998; 22: 603\u2013604.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705016_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/adc.79.1.52","volume":"79","author":"PD Arkwright","year":"1998","unstructured":"Arkwright PD, Makin G, Will AM et al. X linked lymphoproliferative disease in a United Kingdom family. Arch Dis Childhood 1998; 79: 52\u201355.","journal-title":"Arch Dis Childhood"},{"key":"BF1705016_CR34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1182\/blood.V96.4.1239","volume":"96","author":"P Amrolia","year":"2000","unstructured":"Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000; 96: 1239\u20131246.","journal-title":"Blood"},{"key":"BF1705016_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1067\/mpd.2001.112511","volume":"138","author":"UHM Ziegner","year":"2001","unstructured":"Ziegner UHM, Ochs HD, Schanen C et al. Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr 2001; 138: 570\u2013573.","journal-title":"J Pediatr"},{"key":"BF1705016_CR36","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1128\/JCM.38.2.712-715.2000","volume":"38","author":"HG Niesters","year":"2000","unstructured":"Niesters HG, van Esser J, Fries E et al. Development of a real-time quantitative assay for detection of Epstein\u2013Barr virus. J Clin Microbiol 2000; 38: 712\u2013715.","journal-title":"J Clin Microbiol"},{"key":"BF1705016_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0140-6736(03)12513-5","volume":"361","author":"C Antoine","year":"2003","unstructured":"Antoine C, Muller S, Cant A et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968\u20131999. Lancet 2003; 361: 553\u2013560.","journal-title":"Lancet"},{"key":"BF1705016_CR38","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1182\/blood-2003-06-2014","volume":"103","author":"AR Gennery","year":"2004","unstructured":"Gennery AR, Khawaja K, Veys P et al. Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993\u20132002. Blood 2004; 103: 1152\u20131157.","journal-title":"Blood"},{"key":"BF1705016_CR39","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2141.2003.04671.x","volume":"123","author":"C Junghanss","year":"2002","unstructured":"Junghanss C, Storb R, Maris MB et al. Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation. Br J Haematol 2002; 123: 662\u2013670.","journal-title":"Br J Haematol"},{"key":"BF1705016_CR40","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","volume":"99","author":"S Chakrabarti","year":"2002","unstructured":"Chakrabarti S, Mackinnon S, Chopra R et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 2002; 99: 4357\u20134363.","journal-title":"Blood"},{"key":"BF1705016_CR41","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood-2004-03-0960","volume":"105","author":"K Rao","year":"2005","unstructured":"Rao K, Amrolia PJ, Jones A et al. Improved survival after unrelated donor bone marrow transplant in children with primary immunodeficiency using a reduced intensity conditioning regimen. Blood 2005; 105: 879\u2013885.","journal-title":"Blood"},{"key":"BF1705016_CR42","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood.V98.4.972","volume":"98","author":"JW van Esser","year":"2001","unstructured":"van Esser JW, van der Holt B, Meijer E et al. Epstein\u2013Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 2001; 98: 972\u2013978.","journal-title":"Blood"},{"key":"BF1705016_CR43","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1182\/blood.V99.7.2630","volume":"99","author":"AC Lankester","year":"2001","unstructured":"Lankester AC, van Tol MJ, Vossen JM et al. Epstein\u2013Barr virus (EBV)-DNA quantification in pediatric allogeneic stem cell recipients: prediction of EBV-associated lymphoproliferative disease. Blood 2001; 99: 2630\u20132631.","journal-title":"Blood"},{"key":"BF1705016_CR44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.7326\/0003-4819-101-3-310","volume":"101","author":"PJ Martin","year":"1984","unstructured":"Martin PJ, Schulman HM, Schubach WH et al. Fatal Epstein\u2013Barr virus associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T cell antibody. Ann Int Med 1984; 101: 310.","journal-title":"Ann Int Med"},{"key":"BF1705016_CR45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.V72.2.520.520","volume":"72","author":"MM Zutter","year":"1988","unstructured":"Zutter MM, Martin PJ, Sale GE et al. Epstein\u2013Barr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520\u2013529.","journal-title":"Blood"},{"key":"BF1705016_CR46","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood.V91.8.3079.3079_3079_3083","volume":"91","author":"G Hale","year":"1998","unstructured":"Hale G, Waldmann H . Risks of developing Epstein\u2013Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. Blood 1998; 91: 3079\u20133083.","journal-title":"Blood"},{"key":"BF1705016_CR47","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI . Epstein\u2013Barr virus infection. N Engl J Med 2000; 343: 481\u2013491.","journal-title":"N Engl J Med"},{"key":"BF1705016_CR48","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","volume":"92","author":"CM Rooney","year":"1998","unstructured":"Rooney CM, Smith CA, Ng CY et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein\u2013Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549\u20131555.","journal-title":"Blood"},{"key":"BF1705016_CR49","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","volume":"100","author":"JI Henter","year":"2002","unstructured":"Henter JI, Samuelsson-Horne A, Arico M et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002; 100: 2367\u20132373.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705016","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T07:41:08Z","timestamp":1683099668000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,23]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,7,1]]}},"alternative-id":["BF1705016"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705016","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,23]]},"assertion":[{"value":"31 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}